OpenAI is offering its life sciences model GPT-Rosalind for free through the new Rosalind Biodefense program, aimed at pandemic preparedness and biodefense. Early partners include Lawrence Livermore National Laboratory, Johns Hopkins, and vaccine initiative CEPI. Applications are open worldwide.

AI has massive implications for biosecurity, including the creation of biological weapons.

OpenAI invests $30M in Valthos, launches GPT-Rosalind for drug discovery, and partners with Los Alamos to bolster US biodefense and pandemic preparedness.